Alzheimer's Disease: Drugs
Commons · Question 62774 · Tabled 25 Jun 2025 · Department of Health and Social Care · Official record
Answered 3 Jul 2025
Question
Asked by Andrew Snowden
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 June to Question 61301 on Alzheimer's Disease: Drugs, whether NICE has made an assessment of the potential impact of not publishing the economic models for (a) lecanema
Answer
Answered by Karin Smyth, 3 Jul 2025
The National Institute for Health and Care Excellence’s (NICE) single technology appraisal process relies on information provided by companies to evaluate the clinical and cost-effectiveness of new treatments. Some of this information, including the econo...